July 28, 2016 5:55 PM ET


Company Overview of Tibotec-Virco NV

Company Overview

Tibotec-Virco NV and its subsidiaries operate as a biotechnology company. The company develops drugs and individualized disease management products, services, and technologies for HIV/AIDS. It has early stage research programs concentrating on the development of treatments for cancer, hepatitis C, and other infectious diseases. The company also provides HIV drug resistance testing and other analytical services in the United States, Japan, Europe, Canada, and Australia. It has operations in Mechelen, Belgium; Durham, North Carolina; and Dublin, Ireland, as well as in the United States and the United Kingdom. The company was founded in 2001 and is headquartered in Mechelen, Belgium. As of Apri...

Gen De Wittelaan L 11B 3

Mechelen,  2800


Founded in 2001


32 1 529 31 00


32 1 528 63 47

Key Executives for Tibotec-Virco NV

Tibotec-Virco NV does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Amakem NV Europe
Aminolabs SA Europe
Apotheek Delestre NV Europe
Apotheek Moons NV Europe
Apotheek Philips NV Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Tibotec-Virco NV, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.